Large payer covers new technology
Prudential Healthcare in Newark, NJ, recently announced it will reimburse for the AutoPap Primary Pap Smear Screening System developed by NeoPath in Redmond, WA.
The AutoPap System uses proprietary visual intelligence technology to identify Pap smears that have a high likelihood of abnormality. The U.S. Food and Drug Administration in Washing ton, DC, approved the AutoPap system in May 1998 as the first fully automated device for initial screening of Pap smear slides. In clinical studies, AutoPap performed significantly better than current practice in early detection of cervical cancer, according to NeoPath.
Prudential Healthcare is a business unit of The Prudential Insurance Company of America and provides health coverage to more than 5 million members through its managed care networks.
(For more information, visit NeoPath’s home page at www.neopath.com.)